Page last updated: 2024-08-24

dexfenfluramine and Hypertrophy, Right Ventricular

dexfenfluramine has been researched along with Hypertrophy, Right Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antier, D; Apfeldorfer, CS; Desbuards, N; Hanton, G; Hyvelin, JM; Rochefort, GY; Schenck, E1
Brindley, DN; DeAlmeida, J; Mitani, Y; Mutlu, A; Rabinovitch, M; Russell, JC1

Other Studies

2 other study(ies) available for dexfenfluramine and Hypertrophy, Right Ventricular

ArticleYear
Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
    European journal of pharmacology, 2009, Jan-14, Volume: 602, Issue:2-3

    Topics: Animals; Appetite Depressants; Dexfenfluramine; Enzyme Activation; Female; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Weight Gain

2009
Dexfenfluramine protects against pulmonary hypertension in rats.
    Journal of applied physiology (Bethesda, Md. : 1985), 2002, Volume: 93, Issue:5

    Topics: Animals; Appetite Depressants; Body Weight; Dexfenfluramine; Eating; Endothelium, Vascular; Female; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Monocrotaline; Myocardium; Nitric Oxide Synthase; Obesity; Organ Size; Pancreatic Elastase; Pulmonary Artery; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Vascular Diseases

2002